⚖
Compare Funds
See how two funds stack up side by side, real returns, risk, cost and portfolio overlap.
VS
Key Metrics Comparison
| Metric | NJ Flexi Cap Fund - Growth - Direct Plan | HDFC Pharma and Healthcare Fund - Growth - Direct Plan |
|---|---|---|
| Snapshot | ||
| AMC | NJ MF | HDFC MF |
| Category | Equity - Flexi Cap Fund | Equity - Sectoral Fund - Pharma & Health Care |
| NAV | ₹12.97 (30 Oct 2026) | ₹21.95 (30 Oct 2026) |
| Rating | ★ | ★★★★★ |
| Benchmark | NIFTY 500 - TRI | BSE Health Care - TRI |
| Fund Manager | Dhaval Patel | Nikhil Mathur |
| Inception | 05 Sep 2023 | 04 Oct 2023 |
| Returns | ||
| 1Y | -6.55% | 22.64% |
| 3Y | 8.91% | 30.41% |
| 5Y | — | — |
| Since Inception | 8.63% | 29.15% |
| Risk | ||
| 15.91 | 14.07 | |
| 1.02 | 0.59 | |
| 0.25 | 1.59 | |
| 0.07 | 21.67 | |
| 0.48 | 3.48 | |
| -11.27% | -9.23% | |
| Costs | ||
| Expense Ratio | 0.87% | 1.03% |
| Exit Load | NIL | 1% on or before 30D, Nil after 30D |
| Min SIP | ₹100 | ₹100 |
| Min Lumpsum | ₹500 | ₹100 |
| Lock-in | None | None |
Min SIP is reported per fund, not per plan, every plan of a fund shares the same figure.
Portfolio Overlap
NJ MF83%
HDFC MF83%
17.2%Only 17.2% of holdings by weight are common between NJ MF and HDFC MF, based on each fund's top 20 disclosed holdings, not the full portfolio.
Common holdingNJ MFHDFC MF
Torrent Pharmaceuticals Ltd.5.55%3.65%
Cipla Ltd.3.63%4.15%
Sun Pharmaceutical Industries Ltd.3.45%8.28%
Alkem Laboratories Ltd.3.26%4.64%
Dr. Reddy's Laboratories Ltd.3.32%3.19%
Category context: Equity vs Equity. Open the full Screener →